Nepal | August 05, 2020

Hydroxychloroquine shows no virus benefit, raises death risk: Study

Agence France Presse
Share Now:

Paris, May 22

A study of nearly 100,000 coronavirus patients has shown no benefit in treating them with anti-viral drugs hydroxychloroquine and chloroquine and even increased the likelihood of them dying in hospital.

Hydroxychloroquine is normally used to treat arthritis but pronouncement from public figures including US President Donald Trump — who announced this week he is taking the drug — has prompted governments to bulk buy the medicine. Chloroquine, on the other hand, is an anti-malarial drug. Both drugs can produce potentially serious side effects, particularly heart arrhythmia.

And neither drug benefitted patients hospitalised with COVID-19, according to a study published today in The Lancet. Looking at the records of 96,000 patients across hundreds of hospitals, they found that administering the drugs actually increased the risk of dying.

They compared outcomes from four groups: those treated with hydroxychloroquine alone, with chloroquine alone, and then two groups given the respective drugs in combination with antibiotics.

There was also a control group of patients not given these treatments.

At the end of the study period around nine per cent of those in the control group had died.

Of those treated with hydroxychloroquine or chloroquine alone, 18 per cent and 16.4 per cent respectively had died.

And those given each drug in combination with antibiotics were even more likely to die: 22.8 per cent with chloroquine and 23.8 per cent with hydroxychloroquine.

The authors estimated that the drugs put patients at up to 45 per cent higher risk of dying from COVID-19 compared with underlying health issues.

“Treatment with chloroquine or hydroxychloroquine does not benefit patients with COVID-19,” said Mandeep Mehra, lead author of the study and executive director of the Brigham and Women’s Hospital Centre for Advanced Heart Disease in Boston.

“Instead, our findings suggest it may be associated with an increased risk of serious heart problems and increased risk of death.”

Despite Trump’s enthusiasm for using hydroxychloroquine for COVID-19 treatment, his own government’s Food and Drug Administration warns against it.

Brazil’s health minister on Wednesday recommended using chloroquine and hydroxychloroquine to treat even mild COVID-19 cases.

Britain has ordered £35 million ($42 million) worth of hydroxychloroquine, despite numerous studies showing it is ineffective in treating COVID-19 and may even be more dangerous than doing nothing.

“Several countries have advocated use of chloroquine and hydroxychloroquine, either alone or in combination, as potential treatments for COVID-19,” said Frank Ruschitzka, director of the Heart Centre at University Hospital Zurich and co-author of the study.

“We now know from our study that the chance that these medications improve outcomes in COVID-19 is quite low.”

Stephen Griffin, associate professor at the University of Leeds’ School of Medicine, said the Lancet research was “potentially a landmark study for COVID-19 therapy”.

“The indications are that these drugs certainly ought not to be used outside of a trial setting where patients can be monitored for complications,” said Griffin, who was not involved in the study.

A version of this article appears in e-paper on May 23, 2020, of The Himalayan Times.

Follow The Himalayan Times on Twitter and Facebook

Recommended Stories:

More from The Himalayan Times:

Nepal COVID-19 Update: 259 new cases, 65 recoveries, one fatality recorded today

KATHMANDU: Nepal’s Health Ministry, in its regular press briefing, shared the latest updates on coronavirus contagion from across the country, and government’s response to the health crisis. As of today, 406,494 tests through Polymerase Chain Reaction (PCR) method have been carried out, w Read More...

Chief of Butwal's Revenue Investigation Office caught red-handed with bribe money

BHAIRAHAWA: A team deployed from the Commission for Investigation of Abuse of Authority (CIAA) arrested Chief of Revenue Investigation Office, Vijaya Rana red-handed while taking bribe from a service seeker in Butwal, on Tuesday. According to Butwal CIAA Office's Communication Officer Suresh Bhus Read More...

India Coronavirus

Worldwide coronavirus cases cross 18.35 million, death toll at 693,958

LONDON: More than 18.35 million people have been reported to be infected by the novel coronavirus globally and 693,958​ have died, according to a Reuters tally. Infections have been reported in more than 210 countries and territories since the first cases were identified in China in December 20 Read More...

Bihar Chief Minister recommends CBI probe into Sushant Singh Rajput's death

KATHMANDU: The Bihar government has decided to recommend a CBI inquiry into the death of Bollywood star Sushant Singh Rajput, on request from his father KK Singh. According to PTI, Chief Minister Nitish Kumar said that he was informed by the Bihar Director General of Police Gupteshwar Pandey abo Read More...

Sunsari local level to reimpose lockdown following traces of community transmission of COVID-19

DHARAN: Following detection of community transmission of coronavirus-infection, local levels in Sunsari have reimposed lockdown restrictions in a bid to control further spread of the pandemic. District headquarters Inaruwa, Duhabi, Ramdhuni and Itahari Municipalities have taken a decision to this Read More...

Large blast in Beirut port area rocks Lebanon's capital, many people hurt

BEIRUT, Aug 4 (Reuters) - A large explosion rocked Beirut on Tuesday, injuring many people as glass shattered and balconies collapsed from the impact, Reuters witnesses said. Lebanon's state news agency NNA and two security sources said the blast had occurred in the port area where there are wa Read More...

After Nepal, Pakistan unveils new political map; Jammu & Kashmir and Ladakh claimed, India retorts

KATHMANDU: On Tuesday, Prime Minister of Pakistan Imran Khan unveiled a new political map of the country including the territories of Jammu & Kashmir and parts of Ladakh. The 'event' unfolded a day ahead of the first anniversary of Indian government's decision to revoke article 370, which gua Read More...